Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
|
|
F-star Therapeutics, Inc. (SBPH)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| Ridgeback Capital Investments L.P. reports a 0.2% stake in F-star Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| Ridgeback Capital Investments L.P. reports a 0.2% stake in F-star Therapeutics, Inc. |
| 02/14/2022 |
SC 13G/A
| Rock Springs Capital Management LP reports a 3.6% stake in F-star Therapeutics, Inc. |
| 02/14/2022 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 4.8% stake in F-Star Therapeutics, Inc. |
| 02/14/2022 |
SC 13G/A
| Boxer Capital, LLC reports a 0% stake in F-Star Therapeutics, Inc. |
| 02/14/2022 |
SC 13G/A
| Ridgeback Capital Investments L.P. reports a 8.9% stake in F-star Therapeutics, Inc. |
| 02/11/2022 |
SC 13G/A
| Atlas Venture Opportunity Fund I, L.P. reports a 2.9% stake in F-star Therapeutics, Inc. |
| 02/10/2022 |
SC 13G/A
| GLAXOSMITHKLINE PLC reports a 3.9% stake in * F-Star Therapeutics, Inc. |
| 02/08/2022 |
SC 13G/A
| Merck KGaA reports a |
| 04/09/2021 |
SC 13G/A
| Ridgeback Capital Investments L.P. reports a 5.4% stake in F-star Therapeutics, Inc. |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 04/08/2020 |
SC 13G/A
| UBS Oncology Impact Fund L.P. reports a 3.5% stake in Spring Bank Pharmaceuticals, Inc. |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2018 |
SC 13G/A
| Eichler Kurt M reports a 5.6% stake in Spring Bank Pharmaceuticals, Inc. |
| 02/06/2018 |
SC 13G/A
| UBS Oncology Impact Fund L.P. reports a 10.6% stake in Spring Bank Pharmaceuticals, Inc. |
| 12/05/2016 |
SC 13G/A
| Peter Lacaillade reports a 7.9% stake in Spring Bank Pharmaceuticals, Inc. |
|
|